S&P 5007,623.68-0.52%DOW52,215.16-1.23%NASDAQ25,955.34-0.21%BTC$80,645.00-0.98%ETH$2,373.55-0.82%GOLD$4,010.00-1.24%OIL$103.44+3.99%

NT

NASDAQ · NTRA

Natera, Inc.

Healthcare · Medical - Diagnostics & Research

$403.95

Up+$2.58 (+0.64%)

Updated Oct 25, 2026, 10:34 AM

SID Score

7.0/10

Composite research score

Smart Money

62/100

Neutral

Market cap: 31.89B
P/E ratio: -102.52
Dividend yield: 0.00%
52-week range: $181.00 – $437.41
Volume: 1.1M
Avg. volume: 1.34M

Price performance · NTRA

NTRA price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 23, 2026

Last close: $403.95
Period change: -1.90%
Period low: $390.79
Period high: $425.64

Daily close

View OHLC price history

NTRA OHLC price history, latest 40 sessions
Date	Open	High	Low	Close	Volume
Oct 23, 2026	$399.945	$408.28	$395.3289	$403.95	1.1M
Oct 22, 2026	$408.47	$416.00	$383.76	$401.37	1.61M
Oct 21, 2026	$404.84	$420.1499	$404.84	$413.38	1.29M
Oct 20, 2026	$400.01	$410.28	$396.09	$405.92	981.42K
Oct 19, 2026	$401.47	$408.205	$397.2005	$399.42	1.33M
Oct 16, 2026	$405.76	$410.6299	$387.26	$393.44	1.58M
Oct 15, 2026	$389.88	$408.82	$384.23	$404.79	1.21M
Oct 14, 2026	$394.40	$405.11	$391.28	$394.75	1.05M
Oct 13, 2026	$396.98	$397.53	$383.01	$395.655	1.14M
Oct 12, 2026	$401.96	$402.40	$387.74	$397.77	935.14K
Oct 9, 2026	$392.90	$407.06	$391.51	$400.71	1.01M
Oct 8, 2026	$387.59	$392.955	$380.39	$390.79	2.44M
Oct 7, 2026	$393.02	$401.09	$383.45	$395.56	2.82M
Oct 6, 2026	$429.01	$437.4083	$394.77	$400.65	2.5M
Oct 5, 2026	$410.32	$427.18	$405.24	$425.64	2.02M
Oct 2, 2026	$409.40	$413.36	$400.996	$410.35	2.16M
Oct 1, 2026	$413.31	$423.4282	$407.37	$408.47	1.86M
Sep 30, 2026	$416.02	$427.4675	$413.29	$413.31	1.85M
Sep 29, 2026	$413.69	$421.64	$409.25	$414.52	2.06M
Sep 28, 2026	$409.02	$417.375	$406.295	$411.77	1.65M

Latest NTRA news

The latest Smart Investors Daily articles mentioning NTRA.

Featured By

Inc.

Nasdaq

Filter news

Filters are reflected in the page URL for sharing and back-button support.

NTRA news

5 matching articles.

Benzinga · Oct 21, 2026

$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today

Natera (NASDAQ:NTRA) has outperformed the market over the past 5 years by 17.81% on an annualized basis producing an average annual return of 28.94%. Currently, Natera has a market capitalization of $57.57 billion.

Yahoo · Oct 20, 2026

Natera (NTRA) Is Expanding Cancer Testing Rapidly. Does Its Valuation Leave Room for Error?

Testing Volume Is Growing Faster Than the Valuation Can Ignore Natera, Inc. (NASDAQ:NTRA) is turning personalized cancer monitoring into a growing clinical service, but its valuation prices in much more than today’s test volumes. Its Signatera platform detects molecular residual disease through circulating tumor DNA, helping clinicians assess whether cancer remains or returns after treatment. […]

Benzinga · Oct 19, 2026

Canaccord Genuity Maintains Buy on Natera, Raises Price Target to $500

Canaccord Genuity analyst Kyle Mikson maintains Natera (NASDAQ:NTRA) with a Buy and raises the price target from $375 to $500.

Yahoo · Oct 19, 2026

Why Natera (NTRA) Stock Is Up Today

Shares of genetic testing company Natera (NASDAQ:NTRA) jumped 2.4% in the afternoon session after the company announced that incorporating phased and structural variants enables ctDNA detection significantly below 1 part per 10 million, elevating molecular residual disease sensitivity ahead of the 2026 ESMO Annual Congress.

Yahoo · Oct 18, 2026

ESMO 2026 Presentations Deepen the Evidence Base for Natera’s Oncology Portfolio and Leadership in Ultrasensitive MRD Technology

AUSTIN, Texas, October 18, 2026--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that 20 abstracts featuring its technology will be presented at the 2026 European Society for Medical Oncology (ESMO) Annual Congress, taking place October 23–26 in Madrid, Spain.